company background image
HOLX logo

Hologic NasdaqGS:HOLX Stock Report

Last Price

US$76.35

Market Cap

US$17.8b

7D

0.03%

1Y

-2.5%

Updated

18 Mar, 2024

Data

Company Financials +

HOLX Stock Overview

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment.

HOLX fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Hologic, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hologic
Historical stock prices
Current Share PriceUS$76.35
52 Week HighUS$87.88
52 Week LowUS$64.02
Beta1.0
1 Month Change3.47%
3 Month Change7.31%
1 Year Change-2.50%
3 Year Change3.27%
5 Year Change63.11%
Change since IPO3,093.73%

Recent News & Updates

Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Feb 22
Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Hologic: Prospects For Growth As Headwinds Disappear

Feb 11

Recent updates

Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Feb 22
Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Hologic: Prospects For Growth As Headwinds Disappear

Feb 11

We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings

Feb 09
We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings

Hologic, Inc. Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next

Feb 06
Hologic, Inc. Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next

We Like These Underlying Return On Capital Trends At Hologic (NASDAQ:HOLX)

Jan 29
We Like These Underlying Return On Capital Trends At Hologic (NASDAQ:HOLX)

The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)

Dec 30
The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)

Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 25%?

Dec 11
Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 25%?

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Nov 08
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Should You Think About Buying Hologic, Inc. (NASDAQ:HOLX) Now?

Oct 25
Should You Think About Buying Hologic, Inc. (NASDAQ:HOLX) Now?

Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement

Sep 28
Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement

Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 35% Above Its Share Price

Aug 29
Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 35% Above Its Share Price

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Jul 31
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Jul 18
Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Return Trends At Hologic (NASDAQ:HOLX) Aren't Appealing

Jun 21
Return Trends At Hologic (NASDAQ:HOLX) Aren't Appealing

Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

May 22
Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Apr 25
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?

Apr 10
What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?

Hologic's (NASDAQ:HOLX) Returns On Capital Are Heading Higher

Mar 13
Hologic's (NASDAQ:HOLX) Returns On Capital Are Heading Higher

Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

Feb 14
Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Jan 18
Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Is Now The Time To Look At Buying Hologic, Inc. (NASDAQ:HOLX)?

Jan 03
Is Now The Time To Look At Buying Hologic, Inc. (NASDAQ:HOLX)?

Shareholders Would Enjoy A Repeat Of Hologic's (NASDAQ:HOLX) Recent Growth In Returns

Dec 02
Shareholders Would Enjoy A Repeat Of Hologic's (NASDAQ:HOLX) Recent Growth In Returns

Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Oct 12
Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Sep 27
Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Hologic announces $1B share buyback program

Sep 26

We Like Hologic's (NASDAQ:HOLX) Returns And Here's How They're Trending

Aug 27
We Like Hologic's (NASDAQ:HOLX) Returns And Here's How They're Trending

Hologic cut to Neutral at BTIG on macro concerns

Jul 18

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Jul 11
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Jun 28
Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 41%?

Jun 15
Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 41%?

Hologic: Unfairly Punished, Or Not? Examination Of Cash Flow And Earnings

Jun 03

Shareholder Returns

HOLXUS Medical EquipmentUS Market
7D0.03%-1.5%-0.1%
1Y-2.5%12.2%28.4%

Return vs Industry: HOLX underperformed the US Medical Equipment industry which returned 12.2% over the past year.

Return vs Market: HOLX underperformed the US Market which returned 28.4% over the past year.

Price Volatility

Is HOLX's price volatile compared to industry and market?
HOLX volatility
HOLX Average Weekly Movement2.3%
Medical Equipment Industry Average Movement8.0%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: HOLX has not had significant price volatility in the past 3 months.

Volatility Over Time: HOLX's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19856,990Steve MacMillanhttps://www.hologic.com

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.

Hologic, Inc. Fundamentals Summary

How do Hologic's earnings and revenue compare to its market cap?
HOLX fundamental statistics
Market capUS$17.82b
Earnings (TTM)US$515.10m
Revenue (TTM)US$3.97b

34.8x

P/E Ratio

4.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HOLX income statement (TTM)
RevenueUS$3.97b
Cost of RevenueUS$1.55b
Gross ProfitUS$2.42b
Other ExpensesUS$1.91b
EarningsUS$515.10m

Last Reported Earnings

Dec 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)2.19
Gross Margin60.99%
Net Profit Margin12.98%
Debt/Equity Ratio55.0%

How did HOLX perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.